Dr Deepak Jadon
Consultant in Rheumatology, Director of the Rheumatology Research Unit & Lead for Psoriatic arthritis

MBBCh(Hons), MRCP, MRCP(Rheum), PhD

Deepak Jadon is a consultant rheumatologist, Director of the Rheumatology Research Unit, and lead for psoriatic arthritis (PsA)


Clinical & research interests

  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Spondyloarthritis
  • Rheumatoid arthritis
  • Musculoskeletal ultrasound
  • Clinical trials of novel therapeutic agents in rheumatology


Specialist clinics

  • Psoriatic arthritis clinic
  • Early inflammatory arthritis clinic with musculoskeletal ultrasound


Member of

  • Royal College of Physicians (London)
  • British Society for Rheumatology
  • Royal Society of Medicine (London)
  • Group for Research of Psoriasis & Psoriatic Arthritis (GRAPPA)



Deepak Jadon is a consultant rheumatologist, Director of the Rheumatology Research Unit, and lead for psoriatic arthritis (PsA) at Addenbrooke’s Hospital, Cambridge. Having grown up in Cardiff, he graduated from the University of Wales College of Medicine in 2003, and then undertook clinical training in rheumatology and general internal medicine in Bath and Bristol between 2007 - 2015. He completed his PhD thesis on ‘biomarkers of psoriatic arthritis phenotypes’ at the Royal National Hospital for Rheumatic Diseases (Bath, UK) in 2015.

Deepak has particular expertise in the investigation and management of psoriatic arthritis (PsA), ankylosing spondylitis (AS), spondyloarthritis (SpA) and rheumatoid arthritis (RA). He is qualified in the use of musculoskeletal ultrasound and as part of a team, will be using it to improve diagnostic accuracy and assessment of disease activity.

His research interests include genetic and serum biomarkers of PsA, AS and SpA, in particular those that predict prognosis and developing psoriatic spondyloarthritis or arthritis mutilans. He has also researched the clinical and radiographic differences between PsA and AS, and juvenile- vs. adult-onset AS. As Director of the Rheumatology Research Unit, he leads on phase 2a – 4 clinical studies of novel therapeutic agents for PsA, AS, SpA and RA.


Recent publications

Jadon D & McHugh NJ. Chapter 3: Laboratory tests for psoriatic arthritis. GRAPPA Textbook of Psoriatic Disease. (edited by Adebajo A, Boehncke H, Gladman D, and Mease P). 2016 (in press)

Emery P, Wakefield R, Estrach C, Karim Z, Thompson R, Chitale S, Ciechomska A, Jadon D. Making the case for the routine use of ultrasound in the management of rheumatoid arthritis: An evidence-based guide to using a targeted ultrasound approach in rheumatoid arthritis management. 2016. Training in Ultrasound Initiative Press.

Jadon D & McHugh NJ. Psoriatic Arthritis: Did you know? Psoriasis and Psoriatic Arthritis Alliance (PAPAA). 2016.

Jadon D, Shaddick G, Tillett W, Korendowych E, Robinson G, McHugh NJ. Psoriatic arthritis mutilans: Characteristics and natural radiographic progression. The Journal of Rheumatology 2015;42(7):1169-76.

Jadon D, Shaddick G, Jobling A, Ramanan AV, Sengupta R. Clinical outcomes and progression to orthopaedic surgery in juvenile versus adult-onset ankylosing spondylitis. Arthritis Care & Research 2015;67(5):651-7.

Jadon D, Nightingale A, McHugh NJ, Lindsay M, Korendowych E, Sengupta R. Systematic review: Serum-soluble bone biomarkers in psoriatic arthritis and psoriatic spondyloarthritis. The Journal of Rheumatology 2015;42(1)21-30.

Jadon D & McHugh NJ. Other seronegative spondyloarthropathies. Medicine 2014;42(5):257-261.

Tillett W, Jadon D, Shaddick G, Sengupta R, de Vries CS, McHugh N. Reliability, feasibility and sensitivity of four peripheral radiographic scores for psoriatic arthritis. Arthritis Care & Research 2014;66(2):311-7.

Jadon D, Sengupta R, Ramanan AV. Editorial: Challenges in the management and research of juvenile-onset ankylosing spondylitis. International Journal of Clinical Rheumatology 2013;8(6):1-3.

Jadon D, Ramanan AV, Sengupta R. Systematic review: Juvenile vs. adult-onset ankylosing spondylitis. The Journal of Rheumatology 2013;40(11):1797-805.

Tillett W, Jadon D, Shaddick G, Cavill C, Korendowych E, de Vries CS, McHugh N. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis 2013;72(8):1358-61.

Jadon D, Ahmed T, Bhalla AK. Chapter 146: Disorders of bone mineralisation - Osteomalacia. Oxford Textbook of Rheumatology (edited by Watts RA, Conaghan P, Denton C, et al.). 2013. 4th edition. Oxford University Press.

Jadon D & McHugh NJ. Chapter 1: Symptoms and diagnosis of Psoriatic Diseases. Psoriatic Arthritis (edited by Veale D). 2013. Future Science Group.

Jadon D, Tillett W, Wallis D, et al. Exploring ankylosing spondylitis-associated ERAP1, IL12B and IL23R polymorphism in psoriatic arthritis. Rheumatology (Oxf) 2012;52(2):261-6.

Tillett W, Costa L, Jadon D, et al. The Classification for Psoriatic Arthritis (CASPAR) criteria: A retrospective feasibility, sensitivity, and specificity study. The Journal of Rheumatology 2012;39(1):154-6.

Biswas M, Smith J, Jadon D, et al. Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clinical Endocrinology (Oxf) 2005;63(1):26-31.